Author

Kun Wang

University of Illinois Urbana-Champaign

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:chicken / avian· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Adam T. NelczykiD· 1 shared Anasuya Das GuptaiD· 1 shared Arashdeep SinghiD· 1 shared Avni Singh· 1 shared Basel HajyousifiD· 1 shared Beining Guo· 1 shared Bingjie SuniD· 1 shared Chi‐Ping DayiD· 1 shared

Activity by Year

2018-2026 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam T. NelczykORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Transient Splicing-Associated Isoform Remodeling Defines Early MAPKi Resistance Adaptation in Melanoma

Sumit Mukherjee, Arashdeep Singh, Sumeet Patiyal, Hyunjeong Joo, Hyungsoo Kim, Lipika R. Pal, Kun Wang, Chi‐Ping Day, Ze’ev A. Ronai, Eytan Ruppin, Sridhar S. Hannenhalli

The paper identifies transient isoform remodeling as a key mechanism in early MAPKi resistance in melanoma, showing it is distinct from gene expression changes and linked to splicing regulators and developmental pathways.

bioRxiv · Oct 28, 2026 · PreprintCancer Biology

Objective curriculum-guided design of multi-property proteins

Longying Liu, Jianquan Zhao, Xiaomin Xie, Simeng Xu, Milong Ren, Xinru Zhang, Zaikai He, Fan Liu, Chungong Yu, Kun Wang, Xinglong Wang, Xinmiao Liang, Xianlong Ye, Dongbo Bu, Han Zhou

This paper introduces OCDesign, a curriculum-guided framework for multi-property protein design, showing that staged objective introduction improves success rates compared to one-shot optimization.

bioRxiv · May 29, 2026 · PreprintBioengineering

Chicken IRF10 suppresses the cGAS-STING-IFN antiviral signaling pathway by targeting IRF7

Sen Jiang, Jingyu He, Kun Wang, Mengjia Lv, Hongjian Han, Bingjie Sun, Nanhua Chen, Wanglong Zheng, Jianzhong Zhu

This study identifies chIRF10 as a suppressor of chicken cGAS-STING-IFN antiviral signaling by inhibiting chIRF7 activation and dimerization.

Frontiers in Immunology · Feb 10, 2026Peer-reviewedImmunology

Cholesterol efflux protein, ABCA1, supports anti-cancer functions of myeloid immune cells

Shruti V. Bendre, Yu Wang, Basel Hajyousif, K C Rajendra, Shounak G. Bhogale, Dhanya Pradeep, Natalia Krawczyńska, Claire P. Schane, Erin Weisser, Avni Singh, Simon Han, Hannah Kim, Lara I. Kockaya, Anasuya Das Gupta, Adam T. Nelczyk, , Erik Russell Nelson

This study identifies ABCA1 as a cholesterol efflux protein that enhances anti-cancer functions of myeloid cells, with clinical relevance in breast tumors.

Science Advances · Jan 1, 2026Peer-reviewedCancer Biology

Population Pharmacokinetics Study of Morinidazole in Patients with Moderate Hepatic Impairment

Yue Kang, Fengyan Xu, Kun Wang, Jing Zhang, Xiaojie Wu, Jufang Wu, Guoying Cao, Jicheng Yu, Beining Guo, Yuancheng Chen, Yingyuan Zhang

This study builds a population pharmacokinetic model of morinidazole in patients with hepatic impairment and provides dosage adjustment strategies based on covariates like disease status and weight.

bioRxiv · May 2, 2018 · PreprintPharmacology & Toxicology